Gyre Therapeutics (GYRE) Revenue Growth (5y) (2015 - 2026)
Gyre Therapeutics (GYRE) Revenue Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Gyre Therapeutics |
554.75 Mn |
540.62 Mn |
8.38 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
72.67% |
| Dec 31, 2025 |
78.88% |
| Sep 30, 2025 |
102.71% |
| Jun 30, 2025 |
74.43% |
| Mar 31, 2025 |
6.15% |
| Mar 31, 2023 |
429.32% |
| Dec 31, 2022 |
216.81% |
| Mar 31, 2022 |
23.99% |
| Dec 31, 2021 |
102.87% |
| Sep 30, 2021 |
84.00% |
| Jun 30, 2021 |
59.69% |
| Mar 31, 2021 |
68.19% |
| Dec 31, 2020 |
79.50% |
| Sep 30, 2020 |
52.29% |
| Jun 30, 2020 |
14.06% |
| Mar 31, 2020 |
89.37% |
| Mar 31, 2018 |
-72.08% |
| Dec 31, 2017 |
-11.63% |
| Sep 30, 2017 |
-16.17% |
| Jun 30, 2017 |
-68.11% |
